ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,460Medicare Part D Prescriptions Filled, Including Refills

Rank: 68 out of 1278

$360K Total Retail Price of All Prescriptions

Rank: 272 out of 1278

349 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
92% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arizona
Lower avg

Schedule Two
Controlled Substances

32% of this provider’s 349 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

11% of this provider’s 349 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 8,191 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$34 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arizona
LISINOPRIL 806 675 1 1
SIMVASTATIN 655 526 2 3
METFORMIN HCL 457 365 3 4
OXYCODONE-ACETAMINOPHEN 456 273 S2 4 29
HYDROCHLOROTHIAZIDE 360 302 5 8
GLIPIZIDE ER 350 318 6 83
OMEPRAZOLE 300 247 7 6
LEVOTHYROXINE SODIUM 274 208 8 2
RANITIDINE HCL 259 217 9 20
METOPROLOL TARTRATE 248 216 10 9
ATENOLOL 206 154 11 11
IBUPROFEN 196 145 12 46
DIOVAN 165 141 13 44
TRAMADOL HCL 163 113 14 25
FENOFIBRATE 156 112 15 47
GABAPENTIN 152 107 16 12
AMLODIPINE BESYLATE 148 139 17 5
INSULIN SYRINGE 146 115 18 50
FUROSEMIDE 144 131 19 10
LANTUS 133 95 20 33
CLOPIDOGREL 132 110 21 45
PROVENTIL HFA 123 93 22 186
ALENDRONATE SODIUM 122 117 23 18
CARISOPRODOL 110 37 R 24 51
PANTOPRAZOLE SODIUM 110 61 24 34
MELOXICAM 107 83 26 57
PLAVIX 106 92 27 64
NAPROXEN 103 88 28 70
NOVOLIN 70-30 96 69 29 160
PROAIR HFA 96 62 29 26
ZOLPIDEM TARTRATE 94 70 31 16
CIPROFLOXACIN HCL 91 63 32 53
CEPHALEXIN 89 62 33 73
HYDROCODONE-ACETAMINOPHEN 84 72 S3 34 7
ALLOPURINOL 82 77 35 36
MORPHINE SULFATE ER 79 55 S2 36 42
ADVAIR DISKUS 78 54 37 49
NIFEDIPINE ER 77 70 38 148
LOSARTAN POTASSIUM 76 70 39 19
CLOTRIMAZOLE-BETAMETHASONE 73 56 40 205
OXYCODONE HCL-ACETAMINOPHEN 63 38 S2 41 76
TERAZOSIN HCL 63 62 41 59
CARVEDILOL 61 58 43 39
WARFARIN SODIUM 56 50 44 17
DOXAZOSIN MESYLATE 56 55 44 69
OXYCODONE HCL 55 18 S2 46 27
GLIPIZIDE XL 54 53 47 101
ATROVENT HFA 51 47 48 201
CYCLOBENZAPRINE HCL 50 22 R 49 62
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 3, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.